A Method for Minimizing the Effects of Biologic Diversity on the Measurement of Tumor Growth Rates

Contemporary Topics in Laboratory Animal Science

Volumn 36, Issue 2, 1997, Pages 80-85

  Davis, Ian D ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442727352     PISSN: 10600558     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Arrick, B. A., A. R. Lopez, F. Elfman, et al. 1992. Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J. Cell Biol. 118:715-726.
2. Winsor, C. P. 1932. The Gompertz curve as a growth curve. Proc. Natl. Acad. Sci 18:1-7.
3. Steel, G. G. 1977. Growth kinetics of tumours. Clarendon Press, Oxford, United Kingdom.
4. Steel, G. G. 1977. p. 21, In Growth kinetics of tumours, Clarendon Press, Oxford, United Kingdom.
5. Laird, A. K. 1966. Postnatal growth of birds and mammals. Growth 30:349-363.
6. Laird, A. K. 1967. Evolution of the human growth curve. Growth 31:345-355.
7. Demicheli, R., R. Foroni, A. Ingrosso, et al. 1989. An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data. Cancer Res. 49:6543-6546.
8. Steel, G. G. 1977. p. 25, In Growth kinetics of tumours, Clarendon Press, Oxford, United Kingdom.
9. Lollini, P. L., M. C. Bosco, F. Cavallo, et al. 1993. Inhibition of tumor growth and enhancement of metastasis after transfection of the γ-interferon gene. Int. J. Cancer 55:320-329.
10. Elkins, K. L., D. L. Ennist, R. K. Winegar, et al. 1994. In vivo delivery of interleukin-4 by a recombinant vaccinia virus prevents tumor development in mice. Hum. Gene Ther. 5:809-820.
11. Plaksin, D., C. Gelber, M. Feldman, et al. 1988. Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene. Proc. Natl. Acad. Sci. U.S.A. 85:4463-4467.
12. Gansbacher, B., K. Zier, B. Daniels, et al. 1990. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172:1217-1224.
13. Hock, H., M. Dorsch, T. Diamantstein, et al. 1991. Interleukin 7 induces CD4+ T cell-dependent tumor rejection. J. Exp. Med. 174:1291-1298.
14. Dorsch, M., H. Hock, U. Kunzendorf, et al. 1993. Macrophage colony-stimulating factor gene transfer into tumor cells induces macrophage infiltration but not tumor suppression. Eur. J. Immunol. 23:186-190.
15. Hock, H., M. Dorsch, U. Kunzendorf, et al. 1993. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon γ. Proc. Natl. Acad. Sci. U.S.A. 90:2774-2778.
16. Aoki, T., K. Tashiro, S. Miyatake, et al. 1992. Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc. Natl. Acad. Sci. U.S.A. 89:3850-3854.
17. Asher, A. L., J.J. Mulé, A. Kasid, et al. 1991. Murine tumor cells transduced with the gene for tumor necrosis factor-α. Evidence for paracrinc immune effects of tumor necrosis factor against tumors. J. Immunol. 146:3227-3234.
18. Laning, J., H. Kawasaki, E. Tanaka, et al. 1994. Inhibition of in vivo tumor growth by the β chemokine, TCA3. J. Immunol. 153:4625-4635.
19. Teng, M. N., B. H. Park, H. K. Koeppen, et al. 1991. Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc. Natl. Acad. Sci. U.S.A. 88:3535-3539.
20. Gastl, G., C. L. Finstad, A. Guarini, et al. 1992. Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res. 52:6229-6236.
21. Bottazzi, B., S. Walter, D. Govoni, et al. 1992. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148:1280-1285.
22. Tahara, H., H. J. Zeh III, W. J. Storkus, et al. 1994. Fibroblasts genetically engineered to secrete murine interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54:18218-18219.
23. Blankenstein, T., Z.H. Qin, K. Überla, et al. 1991. Tumor suppression after tumor cell-targeted tumor necrosis factor α gene transfer. J. Exp. Med. 173:1047-1052.
24. Colombo, M. P., G. Ferrari, A. Stoppacciaro, et al. 1991. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J. Exp. Med. 173:889-897.
25. McBride, W. H., J. D. Thacker, S. Comora, et al. 1992. Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res. 52:3931-3937.
26. Connor, J., R. Bannerji, S. Saito, et al. 1993. Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells. J. Exp. Med. 177:1127-1134.
27. Qin, Z., S. Krüger-Krasagakes, U. Kunzendorf, et al. 1993. Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis. J. Exp. Med. 178:355-360.
28. Usuda, K., Y. Saito, M. Sagawa, et al. 1994. Tumor doubling time and prognostic assessment of patients with primary lung cancer. Cancer 74:2239-2244.
29. Maruta, H., J. Holden, A. Sizeland, et al. 1991. The residues of ras and rap proteins that determine their GAP specificities. J. Biol. Chem. 266:11661-11668.
30. Gossen, M. and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89:5547-5551.
31. Davis, I. D. and A. W. Burgess. Submitted for publication.
32. Tepper, R. I., P. K. Pattengale, and P. Leder. 1989. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57:503-512.